Business Standard

Wednesday, December 25, 2024 | 12:49 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Fortis shareholders vote in favour of ousting Brian Tempest from co's board

Around 88 per cent backed resolution to remove former Ranbaxy CEO

Brian Tempest, former Ranbaxy CEO 	photo: reuters
Premium

Brian Tempest, former Ranbaxy CEO photo: reuters

Aneesh PhadnisSohini Das Mumbai/Ahmedabad
An overwhelming 88 per cent of Fortis shareholders voted in favour of a resolution to remove Brian Tempest, the last of the four old directors, from the board of the hospital chain and unanimously confirmed the appointment of three new independent directors at an extraordinary general meeting (EGM) on Tuesday. 

The shareholders vote went against the promoter entities which voted in favour of Tempest. 

Tempest, former chief executive officer (CEO) of Ranbaxy Laboratories, was appointed by Fortis founders Malvinder Singh and Shivinder Singh, who had to step down from the board in March amid allegations of siphoning off funds and after that

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in